HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Are Seretide and Symbicort useful in COPD?

Abstract
Seretide (fluticasone + salmeterol--Allen & Hanburys) and Symbicort (budesonide + formoterol--AstraZeneca) inhalers have recently been licensed in the UK for the symptomatic treatment of patients with severe chronic obstructive pulmonary disease (COPD) and a history of repeated exacerbations. Advertising for Seretide depicts a man and states that the drug "has improved his ability to breathe and reduced his risk of exacerbations", while promotional claims for Symbicort include benefits in "reducing symptoms" and "improving quality of life". Here we assess the place of these fixed-dose combination inhalers containing a corticosteroid and a long-acting beta 2 agonist in the management of patients with COPD.
Authors
JournalDrug and therapeutics bulletin (Drug Ther Bull) Vol. 42 Issue 3 Pg. 18-21 (Mar 2004) ISSN: 0012-6543 [Print] England
PMID15038079 (Publication Type: Journal Article, Review)
Chemical References
  • Adrenal Cortex Hormones
  • Androstadienes
  • Budesonide, Formoterol Fumarate Drug Combination
  • Drug Combinations
  • Ethanolamines
  • Fluticasone-Salmeterol Drug Combination
  • Budesonide
  • Albuterol
Topics
  • Administration, Inhalation
  • Adrenal Cortex Hormones (administration & dosage, adverse effects)
  • Albuterol (administration & dosage, adverse effects, analogs & derivatives)
  • Androstadienes (administration & dosage, adverse effects)
  • Budesonide (administration & dosage, adverse effects)
  • Budesonide, Formoterol Fumarate Drug Combination
  • Double-Blind Method
  • Drug Combinations
  • Drug Therapy, Combination
  • Ethanolamines (administration & dosage, adverse effects)
  • Fluticasone-Salmeterol Drug Combination
  • Forced Expiratory Volume (drug effects)
  • Humans
  • Pulmonary Disease, Chronic Obstructive (drug therapy)
  • Randomized Controlled Trials as Topic
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: